Product Description: hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1, with an IC50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer[1].
Applications: Cancer-Kinase/protease
Formula: C27H28ClN7O3S
References: [1]Gopalsamy A, et, al. Identification of pyrimidine derivatives as hSMG-1 inhibitors. Bioorg Med Chem Lett. 2012 Nov 1;22(21):6636-41.
CAS Number: 1402452-15-6
Molecular Weight: 566.07
Compound Purity: 99.82
Research Area: Cancer
Solubility: DMSO : 80 mg/mL (ultrasonic)
Target: CDK;GSK-3;mTOR;PI3K